NEW STEP BY STEP MAP FOR TRACLEER

In vitro As well as in vivo evidence demonstrating extensive hepatic metabolism of bosentan implies that liver impairment could appreciably maximize exposure to bosentan.Bosentan is a selected and competitive antagonist at endothelin receptor forms ETA and ETB. Bosentan has a rather increased affinity for ETA receptors than for ETB receptors. The s